Stelia Ntika

Stelia Ntika, PhD, is a scientist specializing in Analytical Development and Quality Control GMP at Procella Therapeutics AB since August 2022, contributing significantly to the GLP-tox campaign and leading workshops on analytical method regulations. As a co-founder of hejfin, an app designed for financial education aimed at women and non-binary individuals, Stelia participated in the KTH pre-incubator program. Stelia's diverse experience includes an internship at the Swedish Institute for Standards, impact assessment work on medical device regulations, and as a PhD candidate at Karolinska Institutet, focusing on GLP-1 signaling in the context of thoracic aorta aneurysms. Former roles also include research assistant and regulatory affairs officer in pharmaceuticals. Stelia holds a PhD in Medical Sciences from Karolinska Institutet, a Master's degree in Neurochemistry from Stockholm University, and a Bachelor's degree in Chemistry from the National & Kapodistrian University of Athens.